pros and cons of glp-1 Drugs: For Multiple Chronic Conditions E223: The pros & cons

GLP-1 agonists are pharmaceutical interventions with potent systemic signaling

GLP-1 agonists produce dramatic weight loss (averaging 15-20% total body weight) primarily through central appetite suppression, eliminating hunger and creating pharmaceutical satiety

These include smoking, excessive coffee or alcohol consumption, diabetes, rheumatoid arthritis, thyroid disorders, coeliac disease, Crohns disease, obesity, physical inactivity, chronic stress, and certain long term medications such as proton pump inhibitors and corticosteroids

PubMed pubmed.ncbi.nlm.nih.gov [46] GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity PubMed pubmed.ncbi.nlm.nih.gov [47] Semaglutide for the treatment of obesity PubMed pubmed.ncbi.nlm.nih.gov [48] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [49] GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations PubMed pubmed.ncbi.nlm.nih.gov [50] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [51] Adverse Effects of GLP-1 Receptor Agonists PubMed pubmed.ncbi.nlm.nih.gov [52] Use of glucagon-like-peptide 1 receptor agonist in the treatment of childhood obesity PubMed pubmed.ncbi.nlm.nih.gov [53] A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point

2013;8:e56836

Some people may experience improvements sooner, while others may need longer